MIST Stock Price
MIST
MIST stock price is $0.76 (+10.15% on the day), giving MIST a market cap of $86.21M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MIST Stock Overview
- Price
- $0.76
- Previous close
- $0.69
- Open
- $0.72
- Market cap
- $86.21M
- 1-year price target
- $5.57
- MarketXLS Rank
- 34
About MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which completed Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montréal, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIST | $0.76 | +10.2% | 555.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |